全文获取类型
收费全文 | 1000篇 |
免费 | 31篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 38篇 |
妇产科学 | 8篇 |
基础医学 | 73篇 |
口腔科学 | 18篇 |
临床医学 | 70篇 |
内科学 | 134篇 |
皮肤病学 | 34篇 |
神经病学 | 4篇 |
特种医学 | 99篇 |
外科学 | 119篇 |
综合类 | 270篇 |
预防医学 | 45篇 |
眼科学 | 42篇 |
药学 | 37篇 |
肿瘤学 | 49篇 |
出版年
2023年 | 3篇 |
2022年 | 5篇 |
2021年 | 16篇 |
2020年 | 3篇 |
2019年 | 10篇 |
2018年 | 11篇 |
2017年 | 8篇 |
2016年 | 7篇 |
2015年 | 34篇 |
2014年 | 17篇 |
2013年 | 19篇 |
2012年 | 26篇 |
2011年 | 20篇 |
2010年 | 51篇 |
2009年 | 48篇 |
2008年 | 49篇 |
2007年 | 57篇 |
2006年 | 63篇 |
2005年 | 47篇 |
2004年 | 63篇 |
2003年 | 28篇 |
2002年 | 30篇 |
2001年 | 20篇 |
2000年 | 21篇 |
1999年 | 30篇 |
1998年 | 43篇 |
1997年 | 50篇 |
1996年 | 54篇 |
1995年 | 34篇 |
1994年 | 29篇 |
1993年 | 9篇 |
1992年 | 10篇 |
1991年 | 6篇 |
1990年 | 11篇 |
1989年 | 8篇 |
1988年 | 19篇 |
1987年 | 12篇 |
1986年 | 11篇 |
1985年 | 9篇 |
1984年 | 11篇 |
1983年 | 4篇 |
1982年 | 8篇 |
1981年 | 6篇 |
1980年 | 4篇 |
1978年 | 3篇 |
1977年 | 5篇 |
1976年 | 2篇 |
1975年 | 2篇 |
1968年 | 1篇 |
1966年 | 2篇 |
排序方式: 共有1041条查询结果,搜索用时 0 毫秒
21.
Satpathy M Gallagher P Lizotte-Waniewski M Srinivas SP 《Experimental eye research》2004,79(4):477-486
PURPOSE: Phosphorylation of the regulatory light chain of myosin II (referred to as myosin light chain or MLC) leads to a loss of barrier integrity in cellular monolayers by an increase in the contractility of the cortical actin cytoskeleton. This effect has been examined in corneal endothelial (CE) cells. METHODS: Experiments were performed using cultured bovine CE cells (BCEC). MLC phosphorylation was induced by a thrombin-mediated activation of the proteinase-activated receptor-1 (PAR-1). Expression of MLC kinase (MLCK), a Ca2+/calmodulin-dependent protein kinase that phosphorylates MLC at its Ser-19 and Thr-18 residues, was determined by RT-PCR and Western blotting. Expression of PAR-1, RhoA, and Rho kinase-1 (effector of RhoA) was ascertained by RT-PCR. MLC phosphorylation was assessed by urea-glycerol gel electrophoresis followed by immunoblotting. The effects of Rho kinase-1 and PKC were characterized by using their selective inhibitors, Y-27632 and chelerythrine, respectively. Reorganization of the cytoskeleton was evaluated by the phalloidin staining of actin. [Ca2+]i was measured using Fura-2. The barrier integrity was assayed as permeability of BCEC monolayers to horseradish peroxidase (HRP; 44 kDa). RESULTS: RT-PCR showed expression of MLCK, PAR-1, Rho kinase-1, and RhoA. Western blotting indicated expression of the non-muscle and smooth muscle isoforms of MLCK. Exposure to thrombin induced an increase in [Ca2+]i with the peak unaffected by an absence of extracellular Ca2+. Pre-exposure to thrombin (2 U ml(-1); 2 min) led to mono- and di-phosphorylation of MLC. Under both basal conditions and in the presence of thrombin, MLC phosphorylation was prevented by chelerythrine (10 microm) and Y-27632 (<25 microm). Thrombin led to inter-endothelial gaps secondary to the disruption of the cortical actin cytoskeleton, which under resting conditions was organized as a perijunctional actomyosin ring (PAMR). These responses were blocked by pre-treatment with Y-27632. Thrombin also increased permeability to HRP, which was abolished by pre-treatment with Y-27632. CONCLUSIONS: Thrombin induces MLC phosphorylation in BCEC. The consequent increase in the contractility of the actin cytoskeleton produces a centripetal force resulting in inter-endothelial gaps and a breakdown of barrier integrity. These responses are PKC- and Rho kinase-dependent. [Ca2+]i increase, as well as sensitivity of the thrombin response to PKC and Rho kinase inhibitors, are consistent with the expression of PAR-1 receptors in BCEC. Thrombin-induced hyperpermeability is a model to investigate barrier dysfunction induced by MLC phosphorylation. 相似文献
22.
23.
24.
25.
26.
27.
28.
29.
30.
Lyme disease (or Lyme borreliosis) is caused by a spirochetal bacteria, Borrelia burgdorferi. Increased recognition of the disease and increased exposure to the vector (ticks) capable of spreading B. burgdorferi from animal hosts have resulted in a rise in the number of cases of Lyme borreliosis reported in the United States. There are three stages of the clinical course of Lyme borreliosis; however, not all those infected will have typical manifestations of each stage, such as the arthritis of the third stage. Routine blood cultures will rarely document bacteremia and serologic testing is not yet reliable. Early treatment can prevent later stages of Lyme borreliosis. There is evidence that transmission of B. burgdorferi by blood transfusion is possible, but, to date, there has been no documentation of transfusion- associated Lyme borreliosis. Thus, no new recommendations for screening donors to identify possible carriers of B. burgdorferi are suggested at this time. 相似文献